Physician profile
David J Small
NPI 1093076184
$1,139.25
in general payments reported to CMS, 2019-2025
7 companies · $642 in 2025
The $642 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2021: $21.16 · 2023: $135 · 2024: $230 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,007.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $479.20 | 2023-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $242.65 | 2025 | Ozempic, Wegovy, Rybelsus |
| Hologic Sales and Service, LLC | $141.48 | 2025 | Aptima |
| Genzyme Corporation | $125.14 | 2025 | |
| Edwards Lifesciences Corporation | $110.67 | 2019 | |
| Evofem Biosciences, INC. | $21.16 | 2021 | |
| Merck Sharp & Dohme LLC | $18.95 | 2025 | Gardasil 9, Capvaxive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Small listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.